January 13, 2012 – The U.S. Food and Drug Administration (FDA) is updating healthcare professionals and the public about preliminary findings from ongoing investigations following the voluntary recall of CardioGen-82 last July by the manufacturer, Bracco Diagnostics. CardioGen-82 consists of a generator that is used at clinical sites to produce rubidium (Rb)-82 chloride injection. A CardioGen-82 positron emission tomography (PET) scan is one of a variety of nuclear medicine scans that use radioactive drugs to evaluate myocardial perfusion.

January 12, 2012 — Today Brainlab announced the 500th sale of its ExacTrac patient positioning system for frameless radiosurgery. The scale of uptake highlights physicians continued focus on adopting clinically proven systems for high-precision cancer treatments and their ongoing investment in ensuring access to advanced radiation therapy for patients.

January 12, 2012 – Insurance status doesn’t affect the quantity (or value) of imaging services received by patients in a hospital, in-patient setting, according to a study in the January issue of the Journal of the American College of Radiology.

January 12, 2012 — UT-Southwestern Medical Center in Dallas, Texas, has acquired and installed a high-resolution positron emission tomography (PET) scanner.

January 9, 2012 -- Accuray Incorporated today announced publication of a study describing the clinical outcomes of prostate cancer patients treated with stereotactic body radiotherapy (SBRT) using Accuray's CyberKnife Robotic Radiosurgery System in a manner that mimics high dose rate (HDR) brachytherapy dosing within the prostate gland.